Vascular tissue construction on poly(ε-caprolactone) scaffolds by dynamic endothelial cell seeding: Effect of pore size

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 6, 2012, Pages 451-461

  Mathews, Asha ^a   Colombus, Soumya ^a   Krishnan, V Kalliyana ^a   Krishnan, Lissy K ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Biodegradable polymer; Biomimetic scaffold; Blood vessel; ECM; Endothelial cells; Porosity; Tissue engineering

Indexed keywords

BIODEGRADABLE POLYMERS; BLOOD VESSELS; CELL ENGINEERING; COLLAGEN; CYTOLOGY; DEPOSITION; ELASTIN; GLYCOPROTEINS; MONOLAYERS; NITRIC OXIDE; PORE SIZE; SCAFFOLDS (BIOLOGY); SHEAR STRESS; TISSUE;

BIOMIMETIC SCAFFOLDS; ENDOTHELIAL CELL SEEDING; ENDOTHELIAL-CELLS; EXTRACELLULAR MATRICES; IN-VITRO; IN-VIVO; POLY(Ε CAPROLACTONE); SEEDING EFFECTS; TISSUES ENGINEERINGS; VASCULAR TISSUE;

ENDOTHELIAL CELLS;

ACTIN; BIOMIMETIC MATERIAL; COLLAGEN TYPE 4; ELASTIN; FIBRIN; NITRIC OXIDE; POLYCAPROLACTONE; TISSUE SCAFFOLD;

ARTICLE; BLOOD FLOW; CELL CULTURE; COMPARATIVE STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MATERIAL COATING; MEMBRANE STABILIZATION; MONOLAYER CULTURE; POROSITY; PRIORITY JOURNAL; SURFACE PROPERTY; TISSUE ENGINEERING; VASCULAR TISSUE;

EID: 84860656733     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.449     Document Type: Article

References (34)

1. Anthony R. 2000; Tissue Engineering of vascular grafts. Matrix Biol 19: 353-357.
2. Davids L, Dower T, Zilla P. 1999; The lack of healing in conventional grafts. In Tissue Engineering of Prosthetic Vascular Grafts, Zilla P, Griesler H (eds). Landes: Austin, Texas, USA; 3-44.
3. Dejana E, Colella S, Languino LR, et al. 1987; Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro. J Cell Biol 104: 1403-1411.
4. Divya P, Krishnan LK. 2009; Design of fibrin matrix composition to enhance endothelial cell growth and extra cellular matrix deposition for in vitro tissue engineering. Artif Organs 33: 16-21.
5. Divya P, Krishnan VK, Krishnan LK. 2007; Vascular tissue generation in response to signaling molecules integrated with a novel poly(ε-caprolactone)-fibrin hybrid scaffold. J Tissue Eng Regen Med 1: 389-397.
6. Divya P, Lizymol PP, Minshiya P, et al. 2008; Development of a fibrin composite coated poly(ε-caprolactone) scaffold for potential vascular tissue engineering applications. J Biomed Mater Res 87B: 570-579.
7. Divya P, Sreerekha PR, Krishnan LK. 2007; Growth factors upregulate deposition and remodeling of ECM by endothelial cells cultured for tissue engineering applications. Biomol Eng 24: 593-603.
8. Flemming RG, Murphy CJ, Abrams GA, et al. 1999; Effects of synthetic micro- and nano-structured surfaces on cell behavior. Biomaterials 20: 573-588.
9. Folkman J, Klagsbrun M, Sasse J, et al. 1988; A heparin-binding angiogenic protein basic fibroblast growth factor is stored within basement membrane. Am J Pathol 130: 393-400.
10. Gamble J, Mathias LM, Woeyer G, et al. 1993; Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol 121: 931-943.
11. Jaffe EA, Nachman RL, Becker CG, et al. 1973; Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756.
12. Jin G, Peter C, Robert N, et al. 2008; Co-expression of elastin and collagen leads to highly compliant engineered blood vessels. J Biomed Mater Res 85A: 1120-1128.
13. Kaushal S, Amiel GE, Guleserian KJ, et al. 2001; Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7: 1035-1040.
14. L'Heureux N, Dusserre N, Konig G, et al. 2006; Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 12: 361-365.
15. L'Heureux N, Paquet S, Labbe R, et al. 1998; A completely biological tissue-engineered human blood vessel. FASEB J 12: 47-56.
16. Lee SJ, Yoo JJ, Lim GJ, et al. 2007; In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J Biomed Mater Res 83A: 999-1008.
17. Macarak EJ, Howard PS. 1983; Adhesion of endothelial cells to extracellular matrix proteins. J. Cell Physiol 116: 76-86.
18. Maciag T, Cerundolo J, Ilsley S, et al. 1979; An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 76: 5674-5678.
19. Meyer SR, Chiu B, Churchill TA, et al. 2006; Comparison of aortic valve allograft decellularization techniques in the rat. J Biomed Mater Res 79A: 254-262.
20. Narayan D, Venkatraman SS. 2008; Effect of pore size and interpore distance on endothelial cell growth on polymers. J Biomed Mater Res 87A: 710-718.
21. Niklason LE, Gao J, Abbott WM, et al. 1999; Functional arteries grown in vitro. Science 284: 489-493.
22. Niklason LE. 1999; Replacement arteries made to order. Science 286: 1493-1494.
23. Nishebe T, Ohkashiwa H, Satoh Y, et al. 1996; High-porosity expanded polytetrafluoroethylene grafts with omentum wrap for portal vein replacement: intermediate results. J Hep Bil Pancr Surg 3: 474-479.
24. O'Donnell TF, Mackey W, McCullough JL, et al. 1984; Correlation of operative findings with angiographic and noninvasive hemodynamic factors associated with failure of polytetrafluoroethylene grafts. J Vasc Surg 1: 136-148.
25. Pektok E, Nottelet B, Tille JC, et al. 2008; Degradation and healing characteristics of small-diameter poly(ε-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 118: 2563-2570.
26. Resmi KR, Krishnan LK. 2002; Protease action and generation of β-thromboglobulin-like protein followed by platelet activation. Thromb Res 107: 23-29.
27. Rosenman JE, Kempczinski RF, Pearce WH, et al. 1985; Kinetics of endothelial cell seeding. J Vasc Surg 2: 778-784.
28. Schulick AH, Taylor AJ, Zuo W, et al. 1998; Overexpression of transforming growth factor β1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci USA 95: 6983-6988.
29. Shapira OM, Xu A, Aldea GS, et al. 1999; Enhanced nitric oxide-mediated vascular relaxation in radial artery compared with internal mammary artery or saphenous vein. Circulation 100: 11322-11327.
30. Shin'oka T, Matsumura G, Hibino N, et al. 2005; Mid-term clinical results of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129: 1330-1338.
31. Yamane T, Yamaguchi N, Yoshida Y, et al. 2004; Regulation of extracellular matrix production and degradation of endothelial cells by shear stress. Atherosclerosis XIII Int Congr Ser 1262: 407-410.
32. Yurchenco PD, O'Rear J. 1993; Supramolecular organization of basement membranes. In Molecular and Cellular Aspects of Basement Membranes, Rohrbach DH, Timpl R (eds). Academic Press: San Diego, CA; 19-47.
33. Weijers EM, Van Wijhe MH, Joosten L, et al. 2010; Molecular weight fibrinogen variants alter gene expression and functional characteristics of human endothelial cells. J Thromb Haemost 8: 2800-2809.
34. Zhang X, Wang X, Keshav V, et al. 2009; Dynamic culture conditions to generate silk-based tissue-engineered vascular grafts. Biomaterials 30: 3213-3223.